Mural Oncology
(MURA)
undefined
undefined%
At close: undefined
3.64
0.69%
After-hours Dec 13, 2024, 04:00 PM EST
Company Description
Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer.
The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab.
It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs.
The company was incorporated in 2017 and is based in Dublin, Ireland.
As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.
Mural Oncology
| Country | IE |
| IPO Date | Nov 16, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 107 |
| CEO | Caroline J. Loew Ph.D. |
Contact Details
Address: 10 Earlsfort Terrace Dublin, IE | |
| Website | https://www.muraloncology.com |
Stock Details
| Ticker Symbol | MURA |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001971543 |
| CUSIP Number | n/a |
| ISIN Number | IE000LK2BOB4 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Caroline J. Loew Ph.D. | President, Chief Executive Officer & Director |
| Adam D. Cutler B.A. | Chief Financial Officer, Principal Financial Officer & Principal Accounting Officer |
| Maiken Keson-Brookes | Chief Legal Officer |
| Dr. Vicki L. Goodman M.D. | Chief Medical Officer |
| Justin Levine | Head of Human Resources & Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | SCHEDULE 13G | Filing |
| Nov 14, 2024 | SCHEDULE 13G/A | [Amend] Filing |
| Nov 13, 2024 | S-3 | Filing |
| Nov 13, 2024 | 10-Q | Quarterly Report |
| Nov 13, 2024 | 8-K | Current Report |
| Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 08, 2024 | 4 | Filing |
| Nov 04, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 04, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |